Abstract
The chapter begins with a general discussion of synapses and their neurotransmitters. In humans, all nerve to nerve, nerve to muscle, and peripheral sensory receptor to nerve communication occurs via synapses. An electrical signal traveling along a nerve axon is converted at a specialized nerve ending called a synapse. There are at least 30 different neurotransmitters, with the greatest number occurring in the CNS. Neurotransmitters are classified into simple chemicals (acetylcholine, norepinephrine, dopamine), amino acids (gamma amino butyric acid [GABA], glycine, glutamine), or peptides (substance P, endorphins). Next, the chapter discusses pathological diseases of the synapse called synaptopathies, which may occur from chemical or biologic toxins, antibodies directed against synaptic receptor molecules, or genetic mutations in the synaptic receptor or membrane channel. The major synaptopathies, myasthenia gravis, Lambert–Eaton myasthenic syndrome, and botulism, are reviewed with attention to their pathophysiology, major clinical features, major laboratory findings, and principles of management and prognosis.
A 37-year-old woman presents to her primary care doctor with several months of feeling weak and seeing double. She reports that she first noticed the weakness when the family was moving into a new house. Her husband told her that she looked tired as her eyelids were droopy. Shortly after that, she noticed some double vision late in the day. She noted that packing the kitchen was particularly difficult when moving things from higher shelves down for packing. She had to take several rests in order to complete the packing. She thought this was normal and just related to the stress of moving. But the weakness and fatigue have not gotten better and became worried that something was really wrong. On exam, the patient has ptosis and fatigable weakness on holding her arms outstretched. A glove with ice is placed on her eyes with resolution of the ptosis. A clinical diagnosis of myasthenia gravis was made and the appropriate confirmatory tests were ordered.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Recommended Reading
Spillane J, Beeson DJ, Kullmann DM. Myasthenia and related disorders of the neuromuscular junction. J Neurol Neurosurg Psychiatry. 2010;81:850–7. (Good overview of NMJ disorders)
Sobel J. Botulism. Clin Infect Dis. 2005;41:1167–73. (Good overview of botulism)
Titulaer MG, Lang B, Verschuuren J. Lambert-Eaton myasthenic syndrome: from clinical characteristics to therapeutic strategies. Lancet Neurol. 2011;10:1098–107. (Nice review of Lambert-Eaton syndrome)
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Video Legend
Video Legend
This video shows a 67 year-old man with Myasthenia Gravis.
Segment 1: Symptom Description
-
Patient describes his ocular myasthenia symptoms: diplopia, ptosis and fatigue.
Segment 2: Cranial Nerve Exam
-
Diplopia at both extremes of gaze
-
Binocular diplopia—the diplopia resolves with covering one eye
-
Patient does not have full excursion with lateral gaze
-
Ptosis
-
Divergent gaze due to NMJ weakness
-
Normal jaw and neck strength
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Davis, L., Pirio Richardson, S. (2015). Disorders of the Neuromuscular Junction. In: Fundamentals of Neurologic Disease. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-2359-5_5
Download citation
DOI: https://doi.org/10.1007/978-1-4939-2359-5_5
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-2358-8
Online ISBN: 978-1-4939-2359-5
eBook Packages: MedicineMedicine (R0)